Category: Alumni

William Powderly, MD, reminds the community that the COVID-19 pandemic is still in the first wave of the pandemic and Americans need to continue to take steps to control the spread.

More than 1,000 people in Missouri have died from COVID-19, according to data analyzed by St. Louis Public Radio. The state reached that milestone three months after the first person in the state died from the disease. In a recent St. Louis Public radio story, William Powderly, MD, the J. William Campbell Professor of Medicine, […]

In two and a half weeks Jane O’Halloran, MD and Phil Mudd, MD create COVID-19 specimen bank

In early March, just as the pandemic was gaining steam in the St. Louis region, Jane O’Halloran, MD, PhD, an assistant professor of medicine, and Philip Mudd, MD, PhD, assistant professor of emergency medicine, met to discuss the possibility of creating a COVID-19 specimen bank. Two and a half weeks later, they began collecting their […]

Patients with COVID-19 donate specimens to advance research efforts

Philip Mudd, MD, PhD, above, an assistant professor of emergency medicine, and his colleague, Jane O’Halloran, MD, PhD, assistant professor of medicine, infectious diseases specialist, have led efforts to create a repository for storing and managing specimens collected from patients with COVID-19. To date, more than 7,000 samples, including blood, urine and saliva specimens, have […]

White Coats for Black Lives – ID Division faculty, fellows and staff demonstrate with hundreds of medical professionals for Black Lives Matter outside medical center complex

Washington University medical students organized and led a powerful event that brought together students, residents, faculty and staff in solidarity with those who stand against systemic racism. The White Coats for Black Lives event outside the Barnes-Jewish Hospital complex was held in conjunction with other hospitals across the area and country. A large group from […]

William Powderly, MD talks about COVID-19 investigational drugs and clinical trials on BJC’s “Five Questions with …”

Bill Powderly, MD, J. William Campbell Professor of Medicine & Co-director, Infectious Diseases Division, answers questions about COVID-19 investigational drugs in clinical trials, hosted by Emily Brasel, director of communications for BJC HealthCare. The video is part of “5 Questions with…,” an ongoing series in which leaders answer viewer questions about important Medical Campus topics.

Students, faculty providing coronavirus-related outreach to Latino population (Links to an external site)

Spanish-speaking students, faculty partner with community leaders to offer education aimed at preventing virus’ spread As stay-at-home orders to stem the spread of COVID-19 were announced in March, Austin Ibele, a first-year student at Washington University School of Medicine in St. Louis, investigated whether information about the coronavirus existed in Spanish to alert the area’s […]

On the front lines: Jeffrey Henderson, Infectious diseases specialist describes how COVID-19 plasma therapy works

Infectious diseases specialist Jeffrey Henderson, MD, PhD, an associate professor of medicine and of molecular microbiology at Washington University School of Medicine in St. Louis, explains plasma therapy and how it is being used in patients with COVID-19. Learn more about Henderson’s work and how COVID-19 survivors can donate plasma. This video is part of a series of short videos focusing […]

COVID-19 in-home monitoring program launched

School of Medicine, BJC HealthCare program involves daily check-ins aimed at reducing hospitalizations People with COVID-19 who are seen by Washington University physicians or BJC Medical Group providers, but not sick enough to be hospitalized, can be enrolled in an in-home health monitoring program. With daily check-ins for each patient via smartphone app or phone […]

Steve Lawrence, MD, MSc, associate professor of medicine, Infectious Diseases Division, discusses protective masks along with Dr. Cheri LeBlanc.

During the COVID-19 pandemic, Washington University physicians respond to news and other media outlets to educate the public. On a daily basis, they answer questions submitted to the “Ask the WashU Doctors” series. With the CDC’s recent recommendation to wear cloth face coverings, many people are doing their part to slow the spread of COVID-19. […]

Judith Aberg, MD, and Pablo Tebas, MD, both prior ID Fellows at WashU, are among expert panelists developing NIH COVID-19 Treatment Guidelines “Living Document”

A panel of U.S. physicians, statisticians, and other experts has developed treatment guidelines for coronavirus disease 2019 (COVID-19). These guidelines, intended for healthcare providers, are based on published and preliminary data and the clinical expertise of the panelists, many of whom are frontline clinicians caring for patients during the rapidly evolving pandemic. The guidelines are […]

5 Questions with Hilary Babcock, MD, professor of medicine, infectioius diseasess and Rachael Snyders, BJC Manager, Infection Prevention

Hilary Babcock, infectious disease physician at Washington University and Barnes-Jewish Hospital, and Rachael Snyders, BJC Center for Clinical Excellence infection prevention manager, answer questions about personal protective equipment in this 6-minute video hosted by Emily Brasel, director of communications for BJC HealthCare. The video is part of “5 Questions with…,” an ongoing series in which leaders […]

Washington University performs, the first in St. Louis, transfusion of antibodies from plasma into COVID-19 patient.

Local COVID-19 patient gets experimental treatment based on century-old idea.  Washington University physicians are testing a treatment for COVID-19 that brings back a therapy used during the 1918 Spanish influenza pandemic. The treatment involves transfusing antibodies from the plasma of recovered COVID-19 patients into patients battling COVID-19 infection. On Saturday, as reported by KSDK, doctors […]

Caline Mattar, MD, co-investigator of study to evaluate antidepressant as potential COVID-19 treatment

Drug fluvoxamine may help prevent life-threatening ‘cytokine storm’ Researchers at Washington University School of Medicine in St. Louis are launching a clinical trial in patients who have tested positive for COVID-19 but who are not sick enough to be hospitalized. The trial is investigating whether the antidepressant medication fluvoxamine, which is currently used to treat […]

Clinical trial launches to evaluate antimalarial drugs for COVID-19 treatment (Links to an external site)

Cigna/Express Scripts provided the drugs; open to COVID-19 patients at Barnes-Jewish Hospital Washington University School of Medicine in St. Louis is launching a clinical trial for patients hospitalized with COVID-19 at Barnes-Jewish Hospital. The trial will investigate the effectiveness of different combinations of the antimalarial drugs chloroquine and hydroxychloroquine and the antibiotic azithromycin in treating […]

Infectious Disease faculty member, Steve Lawrence, MD, warns St. Louis has a brief window of opportunity to slow the coronavirus

Steven J. Lawrence, MD, MSc, Associate Professor of Medicine and Assistant Dean for Curriculum and Clinical Sciences, Office of Medical Student Education, has played an important role in communicating information about the COVID-19 pandemic to the St. Louis community.  He has responded to countless requests for interviews by radio and television outlets. Below is a […]

Drs. Bill Powderly, Jeff Milbrandt, and Sean Whelan lead COVID-19 research governance structure at Washington University

University creates COVID-19 research governance structure Basic and clinical research relevant to COVID-19 are essential activities at Washington University. Conducting this research in the midst of a health-care system responding to a global pandemic poses a number of challenges, which the university is actively working to surmount. Even as we respect the enormous pressures facing […]